Production of serum amyloid A in response to inflammatory cytokines by human adipocytes

European Journal of Inflammation

Volumn 8, Issue 2, 2010, Pages 99-105

  Calabrò, Paolo ^a   Riegler, L ^a   Limongelli, G ^a   Maddaloni, V ^a   Martone, F ^a   Golia, E ^a   D'Alessandro, R ^a   Pacileo, G ^a   Russo, M G ^a   Golino, P ^a   Calabro R ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

Adipose tissue; Atherosclerosis; Cytokines; Inflammation; Obesity

Indexed keywords

15 DEOXY DELTA12,14 PROSTAGLANDIN J2; ACETYLSALICYLIC ACID; FENOFIBRATE; FLUINDOSTATIN; INTERLEUKIN 1; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; SERUM AMYLOID A; TROGLITAZONE; TUMOR NECROSIS FACTOR ALPHA;

ABDOMINAL FAT; ADIPOCYTE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; GLYCOPROTEIN SYNTHESIS; HUMAN; HUMAN CELL; INFLAMMATION; PROADIPOCYTE;

EID: 77957924797     PISSN: 1721727X     EISSN: None     Source Type: Journal    
DOI: 10.1177/1721727X1000800207     Document Type: Article

References (24)

1. Eckel RH, Krauss RM. American Heart Association call to action: obesity as a major risk factor for coronary heart disease. AHA Nutrition Committee. Circulation 1998; 97:2099-100. (Pubitemid 28262114)
2. Grundy SM. Obesity, metabolic syndrome, and coronary atherosclerosis. Circulation 2002; 105:2696-8. (Pubitemid 34615135)
3. Sowers JR. Obesity as a cardiovascular risk factor. Am J Med 2003; 115(S):37-41.
4. Calabro P, Yeh ET. Obesity, inflammation, and vascular disease: the role of the adipose tissue as an endocrine organ. Subcell Biochem 2007; 42:63-91.
5. Calabro P, Limongelli G, Pacileo G, Di Salvo G, Golino P, Calabro R. The role of adiposity as a determinant of an inflammatory milieu. J Cardiovasc Med (Hagerstown) 2008; 9:450-60. (Pubitemid 351521626)
6. Benditt EP, Eriksen N. Amyloid protein SAA is associated with high density lipoprotein from human serum. Proc Natl Acad Sci USA 1977; 74:4025-8. (Pubitemid 8197767)
7. Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999; 340:448-54. (Pubitemid 29084777)
8. Moshage HJ, Roelofs HM, van Pelt JF, Hazenberg BP, van Leeuwen MA, Limburg PC, Aarden LA, Yap SH. The effect of interleukin-1, interleukin-6 and its interrelationship on the synthesis of serum amyloid A and C-reactive protein in primary cultures of adult human hepatocytes. Biochem Biophys Res Commun 1988; 155:112-7.
9. Kumon Y, Suehiro T, Hashimoto K, Sipe JD. Dexamethasone, but not IL-1 alone, upregulates acute-phase serum amyloid a gene expression and production by cultured human aortic smooth muscle cells. Scand J Immunol 2001; 53:7-12. (Pubitemid 32113351)
10. Kovacevic A, Hammer A, Stadelmeyer E, et al. Expression of serum amyloid A transcripts in human bone tissues, differentiated osteoblast-like stem cells and human osteosarcoma cell lines. J Cell Biochem 2008; 103:994-1004. (Pubitemid 351240633)
11. Meek RL, Urieli-Shoval S, Benditt EP. Expression of apolipoprotein serum amyloid A mRNA in human atherosclerotic lesions and cultured vascular cells: implications for serum amyloid A function. Proc Natl Acad Sci USA 1994; 91:3186-90. (Pubitemid 24130200)
12. Fyfe AI, Rothenberg LS, DeBeer FC, Cantor RM, Rotter JI, Lusis AJ. Association between serum amyloid A proteins and coronary artery disease: evidence from two distinct arteriosclerotic processes. Circulation 1997; 96:2914-9. (Pubitemid 27500090)
13. Poitou C, Viguerie N, Cancello R, et al. Serum amyloid A: production by human white adipocyte and regulation by obesity and nutrition. Diabetologia 2005; 48:519-28. (Pubitemid 40487299)
14. Yang RZ, Lee MJ, Hu H, et al. Acute-phase serum amyloid A: an inflammatory adipokine and potential link between obesity and its metabolic complications. PLoS Med 2006; 3:e287.
15. Calabrò P, Chang DW, Willerson JT, Yeh ET. Release of C-reactive protein in response to inflammatory cytokines by human adipocytes: linking obesity to vascular inflammation. J Am Coll Cardiol 2005; 46:1112-3. (Pubitemid 41316523)
16. O'Brien KD, Brehm BJ, Seeley RJ, Bean J, Wener MH, Daniels S, D'Alessio DA. Diet-induced weight loss is associated with decreases in plasma serum amyloid a and C-reactive protein independent of dietary macronutrient composition in obese subjects. J Clin Endocrinol Metab 2005; 90:2244-9. (Pubitemid 40586269)
17. Sjöholm K, Palming J, Olofsson LE, et al. A microarray search for genes predominantly expressed in human omental adipocytes: adipose tissue as a major production site of serum amyloid A. J Clin Endocrinol Metab 2005; 90:2233-9. (Pubitemid 40586267)
18. Mohanty P, Aljada Y, Ghanim H, Hofmeyer D, Tripathy D, Syed T, Al-Haddad W, Dhindsa S, Andona P. Evidence for a potent anti-inflammatory effect of rosiglitazone. J Clin Endocrinol Metab 2004; 89:2728-35.
19. Peelman F, Waelput W, Iserentant H, Lavens D, Eyckerman S, Zabeau L, Tavemier J. Leptin: linking adipocyte metabolism with cardiovascular and autoimmune diseases. Prog Lipid Res 2004; 43:283-301. (Pubitemid 38952616)
20. Ouchi N, Kihara S, Arita Y, et al. Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation 1999; 100:2473-6. (Pubitemid 30005109)
21. Shuldiner AR, Yang R, Gong DW. Resistin, obesity and insulin resistance - the emerging role of the adipocyte as an endocrine organ. N Engl J Med 2001; 345:1345-6.
22. Bulló-Bonet M, García-Lorda P, López-Soriano FJ, Argilés JM, Salas-Salvadó J. Tumour necrosis factor, a key role in obesity? FEBS Lett 1999; 451:215-9. (Pubitemid 29243779)
23. Yudkin JS, Kumari M, Humphries SE, Mohamed-Ali V. Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link? Atherosclerosis 2000; 148:209-14. (Pubitemid 30064452)
24. Lin Y, Rajala MW, Berger JP, Moller DE, Barzilai N, Scherer PE. Hyperglycemia-induced production of acute phase reactants in adipose tissue. J Biol Chem 2001; 276:42077-83.